LUDIVINA BARIBEAU: Open Payments
NPI 1649782400 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 53 payments from 11 companies in 2025. Trend: 2023 $803 · 2024 $1,345 · 2025 $1,088
Food & beverage: $988Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $225 |
| Janssen Biotech, Inc. | 10 | $206 |
| UCB, Inc. | 7 | $179 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $114 |
| Lilly USA, LLC | 4 | $96 |
| Galderma Laboratories, L.P. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Organon LLC | 3 | $42 |
| GENZYME CORPORATION | 1 | $19 |
Products named: TREMFYA, RINVOQ, Bimzelx, ILUMYA, DUPIXENT, NEMLUVIO, TALTZ, EBGLYSS.
Industry payments across TX — which companies pay providers there.
